TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to extend life for elderly lymphoma patients
Disease control OngoingThis study looks at whether adding an oral drug (CC-486) to standard chemotherapy (R-miniCHOP) can help people aged 75 and older with newly diagnosed aggressive B-cell lymphomas live longer without their cancer returning. About 422 participants will receive either the standard tr…
Matched conditions: TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New combo therapy for lymphoma shows promise in early trial
Disease control TerminatedThis early-stage trial tests a new drug, zanubrutinib, added to a standard chemotherapy cocktail (R-PolaCHP) for people newly diagnosed with diffuse large B-cell lymphoma. The main goal is to find the safest dose and watch for side effects. About 38 adults with this type of lymph…
Matched conditions: TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Yazeed Sawalha • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC